Cancer in Humans

Clinical Results on Acupuncture in Cancer-Treatment

Notes from my Casebook

Cancer-article for Veterinary Acupuncture Journal

Are Simeon Thoresen, DVM
Leikvollgata 31
3213 Sandefjord
Norway
arethore@online.no


History

In 1984 I first tried out a new method in treating cancer, with very promising results in a Dachshund (Thoresen 2002). The dog had mammary cancer (multiple tumours along the nipple line) and had begun to develop dyspnoea - it probably had several lung metastases. I treated the ECIWO-point on the liver meridian where it runs along the metatarsal bone I (see rationale below), and in a few weeks the tumours had disappeared almost completely. The dog died several years later from a kidney deficiency.

Also, in 1995 I treated a horse with Equine Sarcoid with good results, published in the Journal of the Norwegian veterinary Society, “Norsk Veterinærtidsskrift” (Thoresen 1995).

In 2003 I published my protocol of treating cancer (Thoresen 2003), and in 2008 I published the results of my protocol in 16 cases of Equine Sarcoid (Thoresen 2008).

Since 1984, I have treated almost 600 patients with all kinds of cancer.

Due to the possibility to make an exact meridian diagnosis (on which acupuncture meridian the cancer is situated or started) as required according to the method described in this article, the results were very good in Mammary cancer. For the same reason, the results were also very good in Melanosarcoma. Results in Lymphosarcoma and Brain cancer were good, but not as good as in Mammary cancer and Melanosarcoma. However, my results in Liver cancer were not good; the healing rate was zero in the few liver cancers that I have treated. In Prostate cancer and in Pancreatic cancer the results were good especially after I introduced the ECIWO-points in my protocol, and stopped with the classical acupuncture points.


Introduction

Certain bodily processes or functions, called “feed-back-mechanisms”, control several, if not all, other bodily functions and processes. This is seen on many levels, as the blood-circulation, the nervous system, the mind of man (Ekeland 2000), the production of controlling molecules, like endorphins and other peptides which control several bodily functions (Pohorille 2003). This control may be seen as molecular control, as when androgens like aldosterone control cell cycle transitions in the prostate (Cinar 2001), genetic control, as when siRNA-fragments control gene-expression in eukaryotic cells (Lewis 2002), poteomic control, as when proteolytic hydrolysis via caspase enzymes control cell cycle by introducing apoptosis (Miller 1997) and as cellular control, as when osteoblasts regulate osteoclast formation through cell-to-cell contact with haematopoietic progenitor cells (Udagawa 2003).

Loss of control may cause cancer to develop, and that is the fundament and assumption of this article, and my work with cancer since 1984.

Current conventional treatment of cancer relies mainly on radical surgery, cytotoxic chemotherapy, radiation treatment and attempts to boost immune function by chemical immunostimulation, administering biotechnologically produced specific antibodies, or purified interferon, etc. Research on gene-based therapy is in the early stages. Many of these treatments induce severe adverse effects in the patient, and some of these effects can compromise normal organic function, and lead directly to the death of the patient. For example, some patients given cytotoxic chemotherapy develop myocardial hepatic or kidney lesions that can seriously compromise their lives.

Therefore I will, in this article, argue that it is possible to treat cancer by stimulating the adequate control mechanisms, and by such control cancer with the sole use of acupuncture.

The potential of acupuncture in affecting the immunological system has been shown (Kim et al, 2002, Rogers et al, 1992). These studies report substantial increases of T-lymphocyte proliferation, increase in NK-cell activity, activation of the complementary system, heat-stable mitogenic humoral factors and increase in OKT4 cells. The proofs of effect from acupuncture at the physiological and biochemical level have been very convincing, and acupuncture has for that reason been combined with chemotherapy in cancer treatment trials (Shen & Glapsy, 2001).


Material and methods

Since 1984, I have developed an acupuncture protocol to treat cancer-patients, animal and human. My protocol in cancer therapy uses the controlling functions of acupuncture.

Thus, for example, I stimulate:

LV-meridian
to control cancer of the spleen or stomach. Also of tissues along the course of these meridians, for example cancer of the lower medial tibia (where the SP-meridian passes), or mammary cancer (ST-meridian passes through the nipple).

SP-meridian
to control cancer of the kidney or bladder. Also of the adrenal gland, ovary, oviduct, uterus, cervix, vagina, testicle, spermatic ducts, seminal vesicle, prostate, penis (all directly related to the kidney), or cancer of the tissues along the course of these meridians, for example cancer close to the sacrum.

In the beginning (1984 – 2004) I used the Ting-point of the meridian that I wanted to stimulate, except for when I treated breast cancer. Then I used the ECIWO-point of the breast, situated in the distal part of the metatarsal bone, along the LV meridian (see picture 1.). Later, when I realised that I got better results in treating breast cancer than in any of the other cancer types, I started to use ECIWO-points in treating all types of cancer (and in treating all other types of problems too, as migraine, excema and so on (see other article)).


Picture 1; example of the point used for treating breast cancer.

Picture 1; example of the point used for treating breast cancer.


I change my protocol if clinical improvement does not occur within two weeks.


Cancer treatment in practice

One must make an exact meridian-diagnosis by a simple observation of where the tumour has arisen in relation to the acupuncture-meridians.

To bring most cancers under control usually takes 1-3 acupuncture sessions, at inter-session intervals of circa 4 weeks, range but treatment of very severe cancers may continue for 1-2 years.


Results

The 18 cases described below were from an unbroken sequential series, selected from my casebook by date of presentation between April 22nd 2003 and January 26th 2004; they were not “cherry-picked” to show the best outcomes. Also patients treated before April 22nd 2002 that came in for follow-up from treatment or further examination were included. Results regarding the patients are updated and continued until April 2004.

This report includes ALL veterinary cancer-cases seen or treated within that time window.


Table 1 summarises my treatment protocols and their interim outcomes in 18 patients with confirmed cancer.

Table 1: Summary of my treatment protocols and their interim outcomes

Picture 1; example of the point used for treating breast cancer.


Discussion

As known in western medicine and science, cancer is an uncontrolled state where the cell cycle has lost control and shows continuous progression forming an independent unit, or a tumour (Sherr, 2000-2001). Specifically, causes for this are lack of control at the genetic level, proteomic- or cellular level. Each of these levels finds examples in the literature; at the genetic level mutations in the p53 promoter yield deficient expression of the p53 product thereby leading to uncontrolled transition between the G and S - phases (Miller & Koeffler, 1993). At the proteomic level, mutations in the p53 gene yield a deficient protein which inefficiently binds to the suppressor and cannot manage to “silence” the S - phase of the cell (Yang et al, 2000). Recent evidence suggests also that cancer is inducible at the cellular level, through oncoviruses, such as the Human T-cell Leukaemia/Lymphotropic virus type 1 (Johnson et al, 2001).

Properly used by people trained in basic principles of traditional Chinese medicine (TCM), this protocol has few if any adverse effects. It is based on the following principles:

  1. The normal biological activity of bodily cells is to grow and multiply in an orderly, controlled way. For many animals and plants this process continues throughout life. It is only in the case of highly developed animals that growth and cell division stop at a certain age. It is likewise in these species that cancer becomes a "normal" illness.
  2. Holistic clinicians evaluate the Controlling Processes (CPs) - those that control, or limit, the growth and lifespan of cancerous cells - to be totally normal and essential for health. If growth processes continue throughout life in a controlled way, cancer (uncontrolled processes) occurs to a much smaller degree. The CPs begin to play a more active role when growth is about to stop. They impede further physical development. The higher up the evolutionary tree a species is, the more important normal functioning of these CPs becomes; their importance is maximal in mammals. If the function of the CPs fails, growth processes regain dominance; the cells survive past their normal time to die and cancerous tumours arise.
  3. Many reasons explain functional failure of the CPs. Constant wear-and-tear, and attempts to adapt to day-to-day changes in external and internal environment, stress the CPs of all cellular and bodily functions constantly. In addition to the (external) stressors and stimuli that adversely influence living organisms, the stressors include shock, strain on the psyche, bombardment with unwanted sounds, visual impressions, additives and electromagnetic influences (high voltage cables, geopathic stress, etc). These stressors can lead to strain on, or loss of dominance of, the CPs, and especially normal functioning of the immune system.
  4. The aim of effective cancer therapy and prevention must be to help the patient to maintain the dominance of, or restore the lost function of, the CPs, especially of the immune system. By preventing or limiting immunomediated diseases, including autoimmune diseases and cancer, the immune system is critical for good health. Many methods, from meditation to more or less vegetarian diets, have been developed to re-establish the essential functions of the CPs. But in my experience the most effective of all is to use the controlling abilities of acupuncture, which is really the body’s own processes to restore control.

Thus, the primary aim, the most important function, of holistic medicine is to stimulate the body's own control mechanisms.


From the summary of the results it is impossible to make any solid claims, because there are too few patients, the follow-up period was too short, and additional factors are too unpredictable and uncontrolled. However, some of the individual results are so astonishing and unexpected that they must not go unobserved by the medical community. The overall results indicate that it might be worth trying the described method, and that it needs further investigation.

One thing is especially interesting. I have treated, during the time span mentioned, 5 dogs with mammary tumours of different malignancy. All these patients received no other treatment except acupuncture. In all 5 cases the outcome to acupuncture treatment was positive, and the cancer disappeared.


Acknowledgements

I thank;


References:

  1. Chumakov AM, Miller CW, Chen DL, Koeffler HP. Analysis of p53 transactivation through high-affinity binding sites. Oncogene. 1993 Nov;8(11):3005-11.
  2. Cinar B, Koeneman KS, Edlund M, Prins GS, Zhau HE, Chung LW. Androgen receptor mediates the reduced tumour growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line. Cancer Res. 2001 Oct 1;61(19):7310-7.
  3. Deppert W. The yin and yang of p53 in cellular proliferation. Semin Cancer Biol. 1994 Jun;5(3):187-202. Review.
  4. Ekeland T-J., Placebofenomenet – hvordan kan det forstås, Tidsskr. Nor. Lægeforen. 2000;120:3017-20
  5. Johnson JM, Harrod R, Franchini G.(2001). Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Pathol. 82: 135-47.
  6. Kim KJ, Lee MW, Choi JH, Sung KJ, Moon KC, Koh JK. (2002). Abstract CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture. Br J Dermatol. 146: 882-4.
  7. Kurono Y, Egawa M, Yano T, Shimoo K. (2002). The effect of acupuncture on the coronary arteries as evaluated by coronary angiography: a preliminary report. Am J Chin Med.30: 387-96.
  8. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet. 2002 Sep;32(1):107-8. Epub 2002 Jul 29.
  9. Loeppky RN, Goelzer P. Microsome-mediated oxidation of N-nitrosodiethanolamine (NDELA), a bident carcinogen. Chem Res Toxicol. 2002 Apr;15(4):457-69.
  10. Lu H. C., A complete translation of the Yellow Emperors classic of internal medicine and the difficult classic, translated from the Chinese, The academy of oriental Heritage, Vancouver, Canada, 1978.
  11. Maoshing N. (1995). The Yellow Emperor’s Classic of Medicine. A New translation of the Neijing Suwen with commentary. Shambhala Publications Inc, Boston.
  12. Miller C, Koeffler HP.(1993).P53 mutations in human cancer. Leukaemia. 1993 Suppl 2: S18-21.
  13. Miller DK. The role of the Caspase family of cysteine proteases in apoptosis.Semin Immunol. 1997 Feb;9(1):35-49. Review.
  14. Pohorille A. et al., Membrane peptides and their role in protobiological evolution. Orig Life Evol Biosph. 2003 Apr;33(2):173-97. Rogers PA, Schoen AM, Limehouse J. (1992). Acupuncture for immune-mediated disorders. Literature review and clinical applications. Probl. Vet. Med. 4:162-93
  15. Shen J, Glaspy J. (2001). Acupuncture: evidence and implications for cancer supportive care. Cancer Pract. 9:147-50Tagliaferri M, Cohen I, Tripathy D. (2001). Complementary and alternative medicine in early-stage breast cancer. Semin. Oncol. 28:121-34.
  16. Sherr CJ. (2000-2001). Cell cycle control and cancer. Harvey Lect. 96:73-92.
  17. Thoresen A., Akupunkturbehandling av Equint Sarcoid, Norsk Veterinærtidsskrift, 1995 107, 10
  18. Thoresen A, Veterinærmedisin, Komplementære og Alternative metoder, pp.442-445, ISBN 82-994172-4-4, 621 pages. English edition; ISBN 82-994172-2-8, pages 358-363.
  19. Thoresen A. (2003)Klinische Zwishenergebnisse meniner Studien über Akupunktur bei der Krebsbehandlung: Notizen aus meniner Sammlung vom Fallbeispielen, (Zeitschrift Für Ganzheitliche Tiermedizin 2003; 17: 159-163)
  20. Thoresen A. (2008) Akupunktur bei Equinem Sarcoid (Zeitschrift Für Ganzheitliche Tiermedizin 2008; 22: 199-102)
  21. Udagawa N. The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis. J Bone Miner Metab. 2003;21(6):337-43.
  22. Yang Q, Wesch H, Mueller KM, Bartsch H, Wegener K, Hollstein M. (2000). Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation. Br J Cancer. 82: 763-6.